| Jul 2, 2025 |
Jul 3, 2025 |
Chiang Pichi Luo
|
SVP, Corporate Controller |
Sell |
47.5
|
-264
|
-8.87%
|
✗
|
$1.1K |
| Jul 2, 2025 |
Jul 3, 2025 |
Schiller Mark C.
|
COO |
Sell |
47.5
|
-561
|
-17.00%
|
✗
|
$2.4K |
| Jul 1, 2025 |
Jul 1, 2025 |
To Zung Phuong
|
Chief Development Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 23, 2025 |
Klearman Micki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 23, 2025 |
Kauffman Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 23, 2025 |
Wallace Courtney
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 23, 2025 |
Garner Elizabeth
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 23, 2025 |
COOPER GRAHAM K
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 23, 2025 |
BERGER FRANKLIN M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 23, 2025 |
Fowler John Franklin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 16, 2025 |
Chiang Pichi Luo
|
SVP, Corporate Controller |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 16, 2025 |
To Zung Phoung
|
SVP, Clinical Development |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2025 |
Apr 1, 2025 |
Schiller Mark C.
|
Chief Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2025 |
Apr 1, 2025 |
Belsky Marc
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 4, 2025 |
Mar 5, 2025 |
Belsky Marc
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 4, 2025 |
Mar 5, 2025 |
Schiller Mark C.
|
Chief Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 14, 2025 |
Feb 14, 2025 |
Fowler John Franklin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 9, 2025 |
Jan 13, 2025 |
Schiller Mark C.
|
Chief Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 9, 2025 |
Jan 13, 2025 |
Belsky Marc
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 9, 2025 |
Jan 13, 2025 |
Kirk Christopher J.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 2, 2024 |
Jul 26, 2024 |
Schiller Mark C.
|
Chief Legal Officer |
Sell |
47.5
|
-6,688
|
-16.85%
|
✗
|
$3.9K |
| Jun 20, 2024 |
Jun 21, 2024 |
Wallace Courtney
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 21, 2024 |
Garner Elizabeth
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 21, 2024 |
COOPER GRAHAM K
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 21, 2024 |
Klearman Micki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 21, 2024 |
BERGER FRANKLIN M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 21, 2024 |
Kauffman Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 17, 2024 |
Schiller Mark C.
|
Chief Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 7, 2024 |
Jan 9, 2024 |
Belsky Marc
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 7, 2024 |
Jan 9, 2024 |
Mordwinkin Nicholas Michael
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 8, 2023 |
Nov 9, 2023 |
Kirk Christopher J.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 15, 2023 |
Aug 17, 2023 |
Morningside Venture Investments Ltd
|
10% Owner |
Neutral |
27.5
|
-3,500,000
|
-64.24%
|
✗
|
- |
| Jul 24, 2023 |
Jul 26, 2023 |
Wallace Courtney
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 24, 2023 |
Jul 26, 2023 |
Mordwinkin Nicholas Michael
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 24, 2023 |
Jul 26, 2023 |
Klearman Micki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 24, 2023 |
Jul 26, 2023 |
Kirk Christopher J.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 24, 2023 |
Jul 26, 2023 |
Kauffman Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 24, 2023 |
Jul 26, 2023 |
Henig Noreen
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 24, 2023 |
Jul 26, 2023 |
Garner Elizabeth
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 24, 2023 |
Jul 26, 2023 |
Fowler John Franklin
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 24, 2023 |
Jul 26, 2023 |
COOPER GRAHAM K
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 24, 2023 |
Jul 26, 2023 |
BERGER FRANKLIN M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 24, 2023 |
Jul 26, 2023 |
Belsky Marc
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 20, 2023 |
Jul 24, 2023 |
Kirk Christopher J.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 16, 2023 |
BERGER FRANKLIN M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 16, 2023 |
COOPER GRAHAM K
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 16, 2023 |
Garner Elizabeth
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 16, 2023 |
Kauffman Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 16, 2023 |
Wallace Courtney
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 16, 2023 |
Klearman Micki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 3, 2023 |
Feb 7, 2023 |
Morningside Venture Investments Ltd
|
10% Owner |
Sell |
20.0
|
-65,000
|
-1.18%
|
✗
|
$454K |
| Feb 1, 2023 |
Feb 3, 2023 |
Morningside Venture Investments Ltd
|
10% Owner |
Sell |
20.0
|
-90,000
|
-1.61%
|
✗
|
$637.5K |
| Jan 30, 2023 |
Feb 1, 2023 |
Morningside Venture Investments Ltd
|
10% Owner |
Sell |
20.0
|
-60,000
|
-1.06%
|
✗
|
$419.7K |
| Jan 25, 2023 |
Jan 27, 2023 |
Morningside Venture Investments Ltd
|
10% Owner |
Sell |
30.0
|
-50,000
|
-0.88%
|
✗
|
$342.5K |
| Jan 23, 2023 |
Jan 25, 2023 |
Morningside Venture Investments Ltd
|
10% Owner |
Sell |
17.5
|
-160,000
|
-2.72%
|
✗
|
$1.1M |
| Jan 17, 2023 |
Jan 19, 2023 |
Morningside Venture Investments Ltd
|
10% Owner |
Sell |
51.3
|
-6,114
|
-0.10%
|
✗
|
$41.5K |
| Jan 12, 2023 |
Jan 17, 2023 |
Morningside Venture Investments Ltd
|
10% Owner |
Sell |
51.3
|
-6,971
|
-0.12%
|
✗
|
$47.9K |
| Oct 18, 2022 |
Jan 11, 2023 |
Morningside Venture Investments Ltd
|
10% Owner |
Neutral |
27.5
|
-120,000
|
-1.98%
|
✗
|
- |
| Jan 8, 2023 |
Jan 10, 2023 |
Mordwinkin Nicholas Michael
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 8, 2023 |
Jan 10, 2023 |
Kirk Christopher J.
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 8, 2023 |
Jan 10, 2023 |
Belsky Marc
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 8, 2023 |
Jan 10, 2023 |
Fowler John Franklin
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 8, 2023 |
Jan 10, 2023 |
Henig Noreen
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 5, 2023 |
Jan 9, 2023 |
Morningside Venture Investments Ltd
|
10% Owner |
Sell |
40.0
|
-15,162
|
-0.26%
|
✗
|
$105.4K |
| Dec 29, 2022 |
Jan 5, 2023 |
Morningside Venture Investments Ltd
|
10% Owner |
Sell |
30.0
|
-55,500
|
-0.93%
|
✗
|
$396.2K |
| Nov 10, 2022 |
Nov 14, 2022 |
Fowler John Franklin
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 3, 2022 |
Oct 5, 2022 |
Morningside Venture Investments Ltd
|
10% Owner |
Sell |
30.0
|
-32,312
|
-0.53%
|
✗
|
$283.8K |
| Aug 1, 2022 |
Aug 2, 2022 |
Mordwinkin Nicholas Michael
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 15, 2022 |
Mordwinkin Nicholas Michael
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2022 |
Jun 27, 2022 |
Kirk Christopher J.
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 16, 2022 |
Jun 17, 2022 |
Wallace Courtney
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 16, 2022 |
Jun 17, 2022 |
Kauffman Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 16, 2022 |
Jun 17, 2022 |
Klearman Micki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 16, 2022 |
Jun 17, 2022 |
COOPER GRAHAM K
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 16, 2022 |
Jun 17, 2022 |
BERGER FRANKLIN M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 16, 2022 |
Jun 17, 2022 |
Garner Elizabeth
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 12, 2022 |
May 13, 2022 |
COOPER GRAHAM K
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 18, 2022 |
Mar 22, 2022 |
BERGER FRANKLIN M
|
Director |
Buy |
95.0
|
+80,000
|
9.87%
|
✗
|
$1.3M |
| Jan 5, 2022 |
Jan 7, 2022 |
Henig Noreen
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 5, 2022 |
Jan 7, 2022 |
Fowler John Franklin
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 5, 2022 |
Jan 7, 2022 |
Kirk Christopher J.
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 5, 2022 |
Jan 7, 2022 |
Belsky Marc
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2022 |
Jan 5, 2022 |
Kauffman Michael
|
Director |
Sell |
32.5
|
-5,000
|
-7.28%
|
✓
|
$82.3K |
| Dec 14, 2021 |
Dec 15, 2021 |
Fowler John Franklin
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 9, 2021 |
Dec 10, 2021 |
Wallace Courtney
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 10, 2021 |
Wallace Courtney
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 21, 2021 |
Sep 23, 2021 |
BERGER FRANKLIN M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 28, 2021 |
Jun 30, 2021 |
Sommadossi Jean-Pierre
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 28, 2021 |
Jun 30, 2021 |
Klearman Micki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 28, 2021 |
Jun 30, 2021 |
Kauffman Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 28, 2021 |
Jun 30, 2021 |
Garner Elizabeth
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 28, 2021 |
Jun 30, 2021 |
Dinges Jason
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 28, 2021 |
Jun 30, 2021 |
COOPER GRAHAM K
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 28, 2021 |
Jun 30, 2021 |
BERGER FRANKLIN M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 1, 2021 |
Jun 3, 2021 |
Klearman Micki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 3, 2021 |
Klearman Micki
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 30, 2019 |
Mar 29, 2021 |
Economides Vassiliki
|
SVP, Strategy & External Aff. |
Buy |
85.0
|
+750
|
7.10%
|
✗
|
$7.6K |
| Jan 8, 2021 |
Jan 11, 2021 |
Kirk Christopher J.
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 8, 2021 |
Jan 11, 2021 |
Henig Noreen
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 8, 2021 |
Jan 11, 2021 |
Fowler John Franklin
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |